TABLE 1.
Characteristics of participants (n = 157).
Characteristics | Healthy controls | People with schizophrenia | p-value | ||
n | % | n | % | ||
Total | 47 | 100.0 | 110 | 100.0 | |
Gender | |||||
Male | 30 | 63.8 | 71 | 64.6 | 0.932 |
Female | 17 | 36.2 | 39 | 35.5 | |
Highest education level | |||||
Secondary school or less (grade < 12) | 3 | 6.4 | 47 | 42.7 | <0.001 |
High school or higher (grade ≥ 12) | 44 | 93.6 | 63 | 57.3 | |
Family psychiatric history | |||||
No | 47 | 100.0 | 99 | 90.0 | 0.025 |
Yes | 0 | 0 | 11 | 10.0 | |
Mean | SD | Mean | SD | ||
Age | 40.2 | 11.1 | 42.3 | 12.2 | 0.177 |
Age at illness onset (years) | - | - | 27.6 | 8.2 | |
Duration of treated illness (years) | - | - | 17.6 | 9.8 | |
Duration of untreated illness (months) | - | - | 9.7 | 25.9 | |
Olanzapine dose equivalent | - | - | 13.0 | 7.1 | |
Positive and negative syndrome scale (PANSS) | |||||
Positive | 18.6 | 5.8 | |||
Negative | 19.4 | 6.3 | |||
General | 41.6 | 12.1 | |||
Total score of PANSS | 79.8 | 22.4 |